Publications found:
36,694
Sort by:
Exanthema - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Exanthema - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical a...
January 2022
60 pages
Exosomes - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Exosomes - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical an...
January 2022
60 pages
Exosomes - Pipeline Insight, 2022
US$ 2,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Exosomes - Pipeline Insight, 2022” report provides comprehensive insights about 55+ companies and 70+ pipeline d...
January 2022
200 pages
Exportin-1 protein inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Exportin-1 protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 6+...
January 2022
60 pages
Eye Infections - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Eye Infections - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Eye Neoplasms - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Eye Neoplasms - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
Facial Lines - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Facial Lines - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Factor Xa inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Factor Xa inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 6+ companies and 6+ pipeline...
January 2022
60 pages
Factor XI inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Factor XI inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and 8+ pipeline...
January 2022
60 pages
Failed Back Surgery Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Failed Back Surgery Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the di...
January 2022
60 pages
Fanconi Anemia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fanconi Anemia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Farber's disease - Epidemiology Insight - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Farber's disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...
January 2022
60 pages
Fecal Incontinence - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fecal Incontinence - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Female infertility - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Female infertility - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Fibrocystic Breast Condition - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fibrocystic Breast Condition - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the di...
January 2022
60 pages
Follitropin alfa– Biosimilar Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Follitropin alfa– Biosimilar 2022,” report provides comprehensive insights about 10+ companies and 10+ marketed and pipel...
January 2022
60 pages
Food Allergy – Epidemiology Forecast—2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Food Allergy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Food Hypersensitivity - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Food Hypersensitivity - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Fragile X Syndrome (FXS) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fragile X Syndrome (FXS) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
France Healthcare Outlook Report, 2022
US$ 1,995.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “France Healthcare Outlook 2022,” report provides comprehensive insights about healthcare scenario, regulatory policies an...
January 2022
60 pages
Friedreich's Ataxia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Friedreich's Ataxia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Fuchs Dystrophy - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fuchs Dystrophy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
